Arimoclomol, sold under the brand name Miplyffa, is a medication for the treatment of Niemann–Pick disease type C. It is taken by mouth. The most common...
14 KB (1,242 words) - 20:37, 9 November 2024
Niemann–Pick disease type C (section Arimoclomol)
Jefferson University Lysosomal Disease Testing Lab and the Mayo Clinic. Arimoclomol, sold under the brand name Miplyffa, is a medication for the treatment...
41 KB (4,898 words) - 17:02, 26 October 2024
alfa (Xenpozyme) was approved for medical use in Japan in March 2022. Arimoclomol (Miplyffa) was approved for medical use in the United States in September...
30 KB (3,184 words) - 21:45, 23 October 2024
lost over half of its share value overnight upon disclosing a CRL for arimoclomol, a proposed treatment for Niemann–Pick disease, type C, forcing the company...
7 KB (757 words) - 22:55, 23 July 2024
N07XX14 Edaravone N07XX15 Inotersen N07XX16 Deutetrabenazine N07XX17 Arimoclomol N07XX18 Vutrisiran N07XX19 Sodium phenylbutyrate and ursodoxicoltaurine...
2 KB (282 words) - 23:28, 21 December 2023
Argyrol S.S. arhalofenate (USAN, INN) Aricept arildone (INN) Arimidex Arimoclomol aripiprazole (INN) Aristocort Aristogel Aristospan Arixtra Arlex Arlidin...
4 KB (281 words) - 05:03, 25 September 2024
acid, lithium carbonate, pioglitazone, Ono-2506 (arundic acid), and arimoclomol. Repetitive transcranial magnetic stimulation had been studied in amyotrophic...
19 KB (2,300 words) - 04:51, 19 June 2024